CN106362003A - 一种恶性肿瘤放化疗后巩固治疗的药物组合物 - Google Patents
一种恶性肿瘤放化疗后巩固治疗的药物组合物 Download PDFInfo
- Publication number
- CN106362003A CN106362003A CN201610894619.0A CN201610894619A CN106362003A CN 106362003 A CN106362003 A CN 106362003A CN 201610894619 A CN201610894619 A CN 201610894619A CN 106362003 A CN106362003 A CN 106362003A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- poria
- chemoradiotherapy
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/24—Mucus; Mucous glands; Bursa; Synovial fluid; Arthral fluid; Excreta; Spinal fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/638—Ligustrum, e.g. Chinese privet
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种恶性肿瘤放化疗后巩固治疗的药物组合物,包括以下重量份的原料:黄芪20‑25份,石斛18‑22份,熟地黄19‑23份,女贞子17‑21份,山茱萸16‑20份,仙鹤草10‑15份,大枣11‑16份,贝母12‑17份,蛇舌草8‑12份,人参9‑13份,陈皮7‑11份,半枝莲6‑10份,五灵脂5‑8份,茯苓6‑9份,旱莲草4‑7份;其制备方法包括以下步骤:S1:将黄芪、石斛、人参、陈皮和茯苓粉碎成粗粉,然后将粗粉与熟地黄、女贞子、大枣、贝母和五灵脂混合,混合均匀后放入乙醇中浸泡10‑14h,接着减压回收乙醇,浓缩至相对密度为1.35‑1.40的稠膏。本发明按照祛邪以扶正,邪去正安的原则,精选攻坚破积,化瘀逐瘀,补益气血之药物组建而成,能够配合手术、放疗、化疗后的巩固治疗,制备方法简单。
Description
技术领域
本发明涉及中药制剂技术领域,尤其涉及一种恶性肿瘤放化疗后巩固治疗的药物组合物。
背景技术
肿瘤分为良性肿瘤和恶性肿瘤,一般所说的癌即指恶性肿瘤而言;恶性肿瘤从组织学上分为上皮性的癌和非上皮性的肉瘤及血液癌;良性恶性的区别常根据临床的预后加以判定;恶性肿瘤的细胞能侵犯、破坏邻近的组织和器官;而且,癌细胞可从肿瘤中穿出,进入血液或淋巴系统,这就是癌症如何从原发的部位到其它器官形成新的肿瘤,这个过程就叫癌症转移;恶性肿瘤是严重威胁人类健康的多发病、常见病,其发病率和死亡率均跃居疾病谱首位,是目前危害人类健康及死亡率最高的疾病之一。
放射治疗作为治疗恶性肿瘤的一个重要手段,对于许多癌症可以产生较好效果;但是放疗会产生放射性皮炎、放射性食管炎以及食欲下降、恶心、呕吐、腹痛、腹泻或便秘等诸多毒副反应;化疗是利用化学药物杀死肿瘤细胞、抑制肿瘤细胞的生长繁殖和促进肿瘤细胞的分化的一种治疗方式,它是一种全身性治疗手段对原发灶、转移灶和亚临床转移灶均有治疗作用;化疗可能导致身体虚弱、免疫功能下降、消化障碍、心脏、肾脏毒性、膀胱炎等副作用。
放、化疗虽然目前公认的最有效的方法,但放、化疗同时又是一把双刃剑,它在杀伤肿瘤细胞的同时,还对机体产生一系列的毒副作用,如出现骨髓抑制,外周血白细胞下降等,此外还会削弱恶性肿瘤患者的免疫功能;患者表现以正虚为主,特别以气血阴液不足明显;中医认为放疗的毒副反应或放射损伤,根据其致病特点,应归属中医学中“热邪”、“热毒”、“火邪”之类,其病机主要是射线热毒之邪侵袭人体,伤阴(血)耗气,损阴伤津,导致机体脏腑功能失调所表现出的一系列临床表现;因此中医益气养阴之法可增强体质,提高患者机体免疫力,减轻放疗的毒副反应有其重要的临床意义。
发明内容
基于背景技术存在的技术问题,本发明提出了一种恶性肿瘤放化疗后巩固治疗的药物组合物。
本发明提出的一种恶性肿瘤放化疗后巩固治疗的药物组合物,包括以下重量份的原料:黄芪 20-25份,石斛 18-22份,熟地黄 19-23份,女贞子 17-21份,山茱萸 16-20份,仙鹤草 10-15份,大枣 11-16份,贝母 12-17份,蛇舌草 8-12份,人参 9-13份,陈皮 7-11份,半枝莲 6-10份,五灵脂 5-8份,茯苓 6-9份,旱莲草 4-7份;
其制备方法包括以下步骤:
S1:将黄芪、石斛、人参、陈皮和茯苓粉碎成粗粉,然后将粗粉与熟地黄、女贞子、大枣、贝母和五灵脂混合,混合均匀后放入乙醇中浸泡10-14h,接着减压回收乙醇,浓缩至相对密度为1.35-1.40的稠膏;
S2:将山茱萸、仙鹤草、蛇舌草、半枝莲和旱莲草加水煎煮3-6h,滤过,将滤液减压浓缩至相对密度为1.35-1.45的稠膏,然后将两种
稠膏混合,干燥,粉碎,加入淀粉,混合均匀后,用乙醇制粒,接着干燥,加入滑石粉,混合均匀后,装入胶囊,制得恶性肿瘤放化疗后巩固治疗的药物组合物。
优选地,包括以下重量份的原料:黄芪 21-24份,石斛 19-21份,熟地黄 20-22份,女贞子 18-20份,山茱萸 17-19份,仙鹤草 11-14份,大枣 12-15份,贝母 13-16份,蛇舌草9-11份,人参 10-12份,陈皮 8-10份,半枝莲 7-9份,五灵脂 6-7份,茯苓 7-8份,旱莲草5-6份。
优选地,所述S1中,黄芪、石斛、人参、陈皮和茯苓的重量比为21-24:19-21:10-12:8-10:7-8。
优选地,所述S1中,将黄芪、石斛、人参、陈皮和茯苓粉碎成粗粉,然后将粗粉与熟地黄、女贞子、大枣、贝母和五灵脂混合,混合均匀后放入乙醇中浸泡11-13h,接着减压回收乙醇,浓缩至相对密度为1.36-1.39的稠膏。
优选地,所述S2中,将山茱萸、仙鹤草、蛇舌草、半枝莲和旱莲草加水煎煮4-5h,滤过,将滤液减压浓缩至相对密度为1.37-1.43的稠膏,然后将两种稠膏混合,干燥,粉碎,加入淀粉,混合均匀后,用乙醇制粒,接着干燥,加入滑石粉,混合均匀后,装入胶囊,制得恶性肿瘤放化疗后巩固治疗的药物组合物。
本发明中,所述一种恶性肿瘤放化疗后巩固治疗的药物组合物通过以贝母为原料能够清热润肺、化痰止咳,通过以五灵脂为原料能够疏通血脉、散瘀止痛,通过以半枝莲为原料能够清热解毒、活血祛瘀、消肿止痛、抗癌,通过以蛇舌草为原料能够清热解毒、消痈散结,通过以黄芪、石斛和人参为原料能够有益气固表、敛汗固脱、托疮生肌、利水消肿,通过以茯苓为原料能够利水渗湿、益脾和胃、宁心安神,通过以熟地黄为原料能够补血滋阴、益精填髓,通过以女贞子为原料能够补肾滋阴、养肝明目,通过以山茱萸为原料能够滋补、健胃、利尿、补肝肾、益气血,通过以仙鹤草为原料能够收敛止血、截疟、止痢、解毒,通过以大枣为原料能够提高人体免疫力,并可抑制癌细胞,通过以陈皮为原料能够理气健脾、燥湿化痰,通过以旱莲草为原料能够收敛、止血、补肝肾,本发明按照祛邪以扶正,邪去正安的原则,精选攻坚破积,化瘀逐瘀,补益气血之药物组建而成,能够配合手术、放疗、化疗后的巩固治疗,制备方法简单。
具体实施方式
下面结合具体实施例对本发明作进一步解说。
实施例一
本实施例提出了一种恶性肿瘤放化疗后巩固治疗的药物组合物,包括以下重量份的原料:黄芪 20份,石斛 18份,熟地黄 19份,女贞子 17份,山茱萸 16份,仙鹤草 10份,大枣11份,贝母 12份,蛇舌草 8份,人参 9份,陈皮 7份,半枝莲 6份,五灵脂 5份,茯苓 6份,旱莲草 4份;
其制备方法包括以下步骤:
S1:将黄芪、石斛、人参、陈皮和茯苓粉碎成粗粉,然后将粗粉与熟地黄、女贞子、大枣、贝母和五灵脂混合,混合均匀后放入乙醇中浸泡10h,接着减压回收乙醇,浓缩至相对密度为1.35的稠膏;
S2:将山茱萸、仙鹤草、蛇舌草、半枝莲和旱莲草加水煎煮3h,滤过,将滤液减压浓缩至相对密度为1.35的稠膏,然后将两种稠膏混合,干燥,粉碎,加入淀粉,混合均匀后,用乙醇制粒,接着干燥,加入滑石粉,混合均匀后,装入胶囊,制得恶性肿瘤放化疗后巩固治疗的药物组合物。
实施例二
本实施例提出了一种恶性肿瘤放化疗后巩固治疗的药物组合物,包括以下重量份的原料:黄芪 23份,石斛 20份,熟地黄 21份,女贞子 19份,山茱萸 18份,仙鹤草 13份,大枣14份,贝母 15份,蛇舌草 10份,人参 11份,陈皮 9份,半枝莲 8份,五灵脂 6份,茯苓 8份,旱莲草 5份;
其制备方法包括以下步骤:
S1:将黄芪、石斛、人参、陈皮和茯苓粉碎成粗粉,然后将粗粉与熟地黄、女贞子、大枣、贝母和五灵脂混合,混合均匀后放入乙醇中浸泡12h,接着减压回收乙醇,浓缩至相对密度为1.38的稠膏;
S2:将山茱萸、仙鹤草、蛇舌草、半枝莲和旱莲草加水煎煮4h,滤过,将滤液减压浓缩至相对密度为1.40的稠膏,然后将两种稠膏混合,干燥,粉碎,加入淀粉,混合均匀后,用乙醇制粒,接着干燥,加入滑石粉,混合均匀后,装入胶囊,制得恶性肿瘤放化疗后巩固治疗的药物组合物。
实施例三
本实施例提出了一种恶性肿瘤放化疗后巩固治疗的药物组合物,包括以下重量份的原料:黄芪 25份,石斛 22份,熟地黄 23份,女贞子 21份,山茱萸 20份,仙鹤草 15份,大枣16份,贝母 17份,蛇舌草 12份,人参 13份,陈皮 11份,半枝莲 10份,五灵脂 8份,茯苓 9份,旱莲草 7份;
其制备方法包括以下步骤:
S1:将黄芪、石斛、人参、陈皮和茯苓粉碎成粗粉,然后将粗粉与熟地黄、女贞子、大枣、贝母和五灵脂混合,混合均匀后放入乙醇中浸泡14h,接着减压回收乙醇,浓缩至相对密度为1.40的稠膏;
S2:将山茱萸、仙鹤草、蛇舌草、半枝莲和旱莲草加水煎煮6h,滤过,将滤液减压浓缩至相对密度为1.45的稠膏,然后将两种稠膏混合,干燥,粉碎,加入淀粉,混合均匀后,用乙醇制粒,接着干燥,加入滑石粉,混合均匀后,装入胶囊,制得恶性肿瘤放化疗后巩固治疗的药物组合物。
将实施例一、实施例二和实施例三制得的中药胶囊以每次三克,每日三次的量供给患者患者服用,20天后,患者的疼痛感减弱,肌肉力量稍有恢复;50天后,患者各种症状明显改善。
以上所述,仅为本发明较佳的具体实施方式,但本发明的保护范围并不局限于此,任何熟悉本技术领域的技术人员在本发明揭露的技术范围内,根据本发明的技术方案及其发明构思加以等同替换或改变,都应涵盖在本发明的保护范围之内。
Claims (5)
1.一种恶性肿瘤放化疗后巩固治疗的药物组合物,其特征在于,包括以下重量份的原料:黄芪 20-25份,石斛 18-22份,熟地黄 19-23份,女贞子 17-21份,山茱萸 16-20份,仙鹤草 10-15份,大枣 11-16份,贝母 12-17份,蛇舌草 8-12份,人参 9-13份,陈皮 7-11份,半枝莲 6-10份,五灵脂 5-8份,茯苓 6-9份,旱莲草 4-7份;
其制备方法包括以下步骤:
S1:将黄芪、石斛、人参、陈皮和茯苓粉碎成粗粉,然后将粗粉与熟地黄、女贞子、大枣、贝母和五灵脂混合,混合均匀后放入乙醇中浸泡10-14h,接着减压回收乙醇,浓缩至相对密度为1.35-1.40的稠膏;
S2:将山茱萸、仙鹤草、蛇舌草、半枝莲和旱莲草加水煎煮3-6h,滤过,将滤液减压浓缩至相对密度为1.35-1.45的稠膏,然后将两种稠膏混合,干燥,粉碎,加入淀粉,混合均匀后,用乙醇制粒,接着干燥,加入滑石粉,混合均匀后,装入胶囊,制得恶性肿瘤放化疗后巩固治疗的药物组合物。
2.根据权利要求1所述的一种恶性肿瘤放化疗后巩固治疗的药物组合物,其特征在于,包括以下重量份的原料:黄芪 21-24份,石斛 19-21份,熟地黄 20-22份,女贞子 18-20份,山茱萸 17-19份,仙鹤草 11-14份,大枣 12-15份,贝母 13-16份,蛇舌草 9-11份,人参10-12份,陈皮 8-10份,半枝莲 7-9份,五灵脂 6-7份,茯苓 7-8份,旱莲草 5-6份。
3.根据权利要求1所述的一种恶性肿瘤放化疗后巩固治疗的药物组合物,其特征在于,所述S1中,黄芪、石斛、人参、陈皮和茯苓的重量比为21-24:19-21:10-12:8-10:7-8。
4.根据权利要求1所述的一种恶性肿瘤放化疗后巩固治疗的药物组合物,其特征在于,所述S1中,将黄芪、石斛、人参、陈皮和茯苓粉碎成粗粉,然后将粗粉与熟地黄、女贞子、大枣、贝母和五灵脂混合,混合均匀后放入乙醇中浸泡11-13h,接着减压回收乙醇,浓缩至相对密度为1.36-1.39的稠膏。
5.根据权利要求1所述的一种恶性肿瘤放化疗后巩固治疗的药物组合物,其特征在于,所述S2中,将山茱萸、仙鹤草、蛇舌草、半枝莲和旱莲草加水煎煮4-5h,滤过,将滤液减压浓缩至相对密度为1.37-1.43的稠膏,然后将两种稠膏混合,干燥,粉碎,加入淀粉,混合均匀后,用乙醇制粒,接着干燥,加入滑石粉,混合均匀后,装入胶囊,制得恶性肿瘤放化疗后巩固治疗的药物组合物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610894619.0A CN106362003A (zh) | 2016-10-14 | 2016-10-14 | 一种恶性肿瘤放化疗后巩固治疗的药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610894619.0A CN106362003A (zh) | 2016-10-14 | 2016-10-14 | 一种恶性肿瘤放化疗后巩固治疗的药物组合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106362003A true CN106362003A (zh) | 2017-02-01 |
Family
ID=57895291
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610894619.0A Pending CN106362003A (zh) | 2016-10-14 | 2016-10-14 | 一种恶性肿瘤放化疗后巩固治疗的药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106362003A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108079236A (zh) * | 2018-01-12 | 2018-05-29 | 广西天昌投资有限公司 | 一种具有抗肿瘤功能的金花口服液及其制备方法 |
CN109820956A (zh) * | 2019-04-12 | 2019-05-31 | 张冀 | 一种用于肿瘤化疗后滋补的中药组合物及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102512626A (zh) * | 2011-12-15 | 2012-06-27 | 天长市中医院 | 一种用于恶性肿瘤放化疗后巩固治疗的药物组合物及用途 |
-
2016
- 2016-10-14 CN CN201610894619.0A patent/CN106362003A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102512626A (zh) * | 2011-12-15 | 2012-06-27 | 天长市中医院 | 一种用于恶性肿瘤放化疗后巩固治疗的药物组合物及用途 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108079236A (zh) * | 2018-01-12 | 2018-05-29 | 广西天昌投资有限公司 | 一种具有抗肿瘤功能的金花口服液及其制备方法 |
CN109820956A (zh) * | 2019-04-12 | 2019-05-31 | 张冀 | 一种用于肿瘤化疗后滋补的中药组合物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102671130B (zh) | 一种抗肿瘤的中药 | |
CN101181529B (zh) | 一种治疗肿瘤的中药组合物及其制备方法 | |
CN103356973A (zh) | 一种抗肿瘤的中药 | |
CN104998017A (zh) | 一种排毒、滋阴补肾的中药及其制备方法 | |
CN103316192B (zh) | 一种治疗腰腿痛的中药泡脚液及制备方法 | |
CN106362003A (zh) | 一种恶性肿瘤放化疗后巩固治疗的药物组合物 | |
CN101804175B (zh) | 一种抗癌中药散剂及其制备方法 | |
CN103191391A (zh) | 一种治疗慢性胃炎中药 | |
CN103341013B (zh) | 一种治疗腰腿痛的中药 | |
CN1082376C (zh) | 一种具有祛邪扶正双向治疗作用的抗癌新药 | |
CN105148242A (zh) | 一种用于特禀体质调理的药膳及其制备方法 | |
CN106390060A (zh) | 一种养生足贴及其加工工艺 | |
CN102488783A (zh) | 一种治疗血虚的病症中成药 | |
CN111467414A (zh) | 一种治疗新冠状病毒的中药组合物及制备方法 | |
CN101468184B (zh) | 一种治疗消化系统癌症的药物及其制备方法 | |
CN104623414A (zh) | 一种治疗营养性肥胖的中药组合物 | |
CN1081045C (zh) | 一种抗癌药物组合物及其制备方法 | |
CN103028079A (zh) | 一种预防和治疗脑肿瘤的药物组合物及其制备方法 | |
CN1194717C (zh) | 治疗肺癌的蛇毒胶囊及制备方法 | |
CN104645302A (zh) | 一种减轻脑瘤患者术后化疗恶心呕吐的药物及制备方法 | |
CN105663758A (zh) | 一种含有艾叶的治疗月经不调的中药组合物及其制备方法 | |
CN103860814A (zh) | 一种治疗泌尿结石的中草药配方及其制备方法 | |
CN105521150A (zh) | 一种降血脂中药的制备方法 | |
CN103816433B (zh) | 一种治疗气虚型便秘的中药 | |
CN103028104B (zh) | 一种治疗腹痛的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170201 |
|
RJ01 | Rejection of invention patent application after publication |